Induced Pluripotent Stem Cell (iPSC) Global Market Opportunities And Strategies To 2032

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $5,000	310 Pages	The Business Research Company	April, 2023	BRC17888643

Best Price Guarantee
Price	from $5,000
Length	310 Pages
Publisher	The Business Research Company
Published Date	April, 2023
SKU	BRC17888643

Induced Pluripotent Stem Cell (iPSC) Global Market Opportunities And Strategies To 2032

Induced Pluripotent Stem Cell (iPSC) Global Market Opportunities And Strategies To 2032 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global induced pluripotent stem cell (iPSC) market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis

Description:

Where is the largest and fastest growing market for induced pluripotent stem cell (iPSC)? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The induced pluripotent stem cell (iPSC) market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider induced pluripotent stem cell (iPSC) market; and compares it with other markets.

The report covers the following chapters:

Introduction and Market Characteristics

Brief introduction to the segmentations covered in the market, definitions and explanations about the induced pluripotent stem cell (iPSC) market.

Key Trends

Highlights the major trends shaping the global induced pluripotent stem cell (iPSC) market. This section also highlights likely future developments in the market.

Global Market Size and Growth

Global historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.

Regional Analysis

Historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values and growth and market share comparison by region.

Market Segmentation

Contains the market values (2017-2032) and analysis for each segment by derived cell type, by application and by end-user in the market.

Regional Market Size and Growth

Regional market size (2022), historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.

Competitive Landscape

Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.

Key Mergers and Acquisitions

Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.

Market Opportunities And Strategies

Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.

Conclusions And Recommendations

This section Includes recommendations for induced pluripotent stem cell (iPSC) providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.

Appendix

This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope:

Markets Covered:

1) By Derived Cell Type: Hepatocytes; Fibroblasts; Keratinocytes; Amniotic Cells; Other Derived Cell Types

2) By Application: Academic Research; Drug Discovery And Toxicity Studies; Regenerative Medicine; Cell And Gene Therapy

3) By End-User: Hospitals; Research Laboratories

Companies Mentioned: Fujifilm Holdings Corporation (Fujifilm Cellular Dynamics, Inc); Thermo Fisher Scientific, Inc; Takara Bio, Inc; Lonza Group Ag; Astellas Pharma Inc.

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; induced pluripotent stem cell (iPSC) indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

1. Executive Summary
2. Table Of Contents
3. List Of Figures
4. List Of Tables
5. Report Structure
6. Introduction And Market Characteristics: 6.1. General Market Definition; 6.2. Summary; 6.3. Induced Pluripotent Stem Cell (iPSC) Market Definition And Segmentations; 6.4. Market Segmentation By Derived Cell Type; 6.4.1. Blood Cells; 6.4.2. Hepatocytes; 6.4.3. Fibroblasts; 6.4.4. Keratinocytes; 6.4.5. Amniotic Cells; 6.4.6. Other Derived Cell Types; 6.5. Market Segmentation By Application; 6.5.1. Academic Research; 6.5.2. Drug Discovery And Toxicity Studies; 6.5.3. Regenerative Medicine; 6.5.4. Cell And Gene Therapy; 6.6. Market Segmentation By End-User; 6.6.1. Hospitals; 6.6.2. Research Laboratories
7. Major Market Trends: 7.1. Development of Pluripotent Stem Cells For Parkinson’s Disease (PD); 7.2. Strategic Collaborations And Partnerships; 7.3. Induced Pluripotent Stem Cell iPSC-Derived NK Cells; 7.4. Induced Pluripotent Stem Cell (iPSC) For Cell Therapy; 7.5. Investment In Regenerative Medicine Research And Development; 7.6. Development of iPSC Expansion Medium; 7.7. Personalized iPSC; 7.8. Pluripotent Stem Cells For Type I Diabetes
8. Global Market Size and Growth: 8.1. Market Size; 8.2. Historic Market Growth, 2017 – 2022, Value ($ Million); 8.2.1. Market Drivers 2017 – 2022; 8.2.2. Market Restraints 2017 – 2022; 8.3. Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 8.3.1. Market Drivers 2022 – 2027; 8.3.2. Market Restraints 2022 – 2027
9. Global Induced Pluripotent Stem Cell (iPSC) Market Segmentation: 9.1. Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 9.2. Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 9.3. Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
10. Induced Pluripotent Stem Cell (iPSC) Market, Regional and Country Analysis: 10.1. Global Induced Pluripotent Stem Cell (iPSC) Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 10.2. Global Induced Pluripotent Stem Cell (iPSC) Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11. Asia-Pacific Market: 11.1. Summary; 11.2. Market Overview; 11.2.1. Region Information; 11.2.2. Market Information; 11.2.3. Background Information; 11.2.4. Government Initiatives; 11.2.5. Regulations; 11.2.6. Regulatory Bodies; 11.2.7. Major Associations; 11.2.8. Taxes levied; 11.2.9. Corporate Tax Structure; 11.2.10. Investments; 11.2.11. Major Companies; 11.3. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 11.4. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 11.5. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.6. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.7. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.8. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis; 11.9. China Market; 11.10. Summary; 11.11. Market Overview; 11.11.1. Country Information; 11.11.2. Market Information; 11.11.3. Background Information; 11.11.4. Government Initiatives; 11.11.5. Regulations; 11.11.6. Regulatory Bodies; 11.11.7. Major Associations; 11.11.8. Taxes levied; 11.11.9. Corporate tax structure; 11.11.10. Investments; 11.11.11. Major Companies; 11.12. China Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 11.13. China Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 11.14. China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.15. China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.16. China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.17. India Market; 11.18. India Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 11.19. India Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 11.20. India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.21. India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.22. India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.23. Japan Market; 11.24. Japan Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 11.25. Japan Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 11.26. Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.27. Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.28. Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.29. Australia Market; 11.30. Australia Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 11.31. Australia Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 11.32. Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.33. Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.34. Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.35. Indonesia Market; 11.36. Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 11.37. Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.38. Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.39. Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.40. South Korea Market; 11.41. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 11.42. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 11.43. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.44. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 11.45. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12. Western Europe Market: 12.1. Summary; 12.2. Market Overview; 12.2.1. Region Information; 12.2.2. Market Information; 12.2.3. Background Information; 12.2.4. Government Initiatives; 12.2.5. Regulations; 12.2.6. Regulatory Bodies; 12.2.7. Major Associations; 12.2.8. Taxes levied; 12.2.9. Corporate tax structure; 12.2.10. Investments; 12.2.11. Major Companies; 12.3. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 12.4. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 12.5. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.6. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.7. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.8. Western Europe Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis; 12.9. UK Market; 12.10. UK Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 12.11. UK Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 12.12. UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.13. UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.14. UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.15. Germany Market; 12.16. Germany Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 12.17. Germany Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 12.18. Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.19. Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.20. Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.21. France Market; 12.22. France Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 12.23. France Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 12.24. France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.25. France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 12.26. France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13. Eastern Europe Market: 13.1. Summary; 13.2. Market Overview; 13.2.1. Region Information; 13.2.2. Market Information; 13.2.3. Background Information; 13.2.4. Government Initiatives; 13.2.5. Regulations; 13.2.6. Regulatory Bodies; 13.2.7. Major Associations; 13.2.8. Taxes Levied; 13.2.9. Corporate Tax Structure; 13.2.10. Investments; 13.2.11. Major Companies; 13.3. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 13.4. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 13.5. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 13.6. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 13.7. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 13.8. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis; 13.9. Russia Market; 13.10. Russia Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 13.11. Russia Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 13.12. Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 13.13. Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 13.14. Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14. North America Market: 14.1. Summary; 14.2. Market Overview; 14.2.1. Region Information; 14.2.2. Market Information; 14.2.3. Background Information; 14.2.4. Government Initiatives; 14.2.5. Regulations; 14.2.6. Regulatory Bodies; 14.2.7. Major Associations; 14.2.8. Taxes Levied; 14.2.9. Corporate Tax Structure; 14.2.10. Investments; 14.2.11. Major Companies; 14.3. North America Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 14.4. North America Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 14.5. North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 14.6. North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 14.7. North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 14.8. North America Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis; 14.9. USA Market; 14.10. Summary; 14.11. Market Overview; 14.11.1. Country Information; 14.11.2. Market Information; 14.11.3. Background Information; 14.11.4. Government Initiatives; 14.11.5. Regulations; 14.11.6. Regulatory Bodies; 14.11.7. Major Associations; 14.11.8. Taxes Levied; 14.11.9. Corporate Tax Structure; 14.11.10. Investments; 14.11.11. Major Companies; 14.12. USA Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 14.13. USA Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 14.14. USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 14.15. USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 14.16. USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15. South America Market: 15.1. Summary; 15.2. Market Overview; 15.2.1. Region Information; 15.2.2. Market Information; 15.2.3. Background Information; 15.2.4. Government Initiatives; 15.2.5. Regulations; 15.2.6. Regulatory Bodies; 15.2.7. Major Associations; 15.2.8. Taxes Levied; 15.2.9. Corporate Tax Structure; 15.2.10. Investments; 15.2.11. Major Companies; 15.3. South America Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 15.4. South America Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 15.5. South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 15.6. South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 15.7. South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 15.8. South America Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis; 15.9. Brazil Market; 15.10. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 15.11. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 15.12. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 15.13. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 15.14. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16. Middle East Market: 16.1. Summary; 16.2. Market Overview; 16.2.1. Region Information; 16.2.2. Market Information; 16.2.3. Background information; 16.2.4. Government Initiatives; 16.2.5. Regulations; 16.2.6. Regulatory bodies; 16.2.7. Taxes Levied; 16.2.8. Corporate Tax Structure; 16.2.9. Major Associations; 16.2.10. Investments; 16.2.11. Major Companies; 16.3. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2017 – 2022, Value ($ Million); 16.4. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 16.5. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 16.6. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 16.7. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17. Africa Market: 17.1. Summary; 17.2. Market Overview; 17.2.1. Region Information; 17.2.2. Market Information; 17.2.3. Background Information; 17.2.4. Government Initiatives; 17.2.5. Regulations; 17.2.6. Regulatory bodies; 17.2.7. Major Associations; 17.2.8. Taxes Levied; 17.2.9. Corporate Tax Structure; 17.2.10. Investments; 17.2.11. Major Companies; 17.3. Africa Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million); 17.4. Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 17.5. Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million); 17.6. Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
18. Competitive Landscape and Company Profiles: 18.1. Company Profiles; 18.2. FUJIFILM Holdings Corporation; 18.2.1. Company Overview; 18.2.2. Products And Services; 18.2.3. Business Strategy; 18.2.4. Financial Overview; 18.3. Thermo Fisher Scientific, Inc; 18.3.1. Company Overview; 18.3.2. Products And Services; 18.3.3. Business Strategy; 18.3.4. Financial Overview; 18.4. Takara Bio, Inc; 18.4.1. Company Overview; 18.4.2. Products And Services; 18.4.3. Business Strategy; 18.4.4. Financial Overview; 18.5. Lonza Group AG; 18.5.1. Company Overview; 18.5.2. Products And Services; 18.5.3. Business Strategy; 18.5.4. Financial Overview; 18.6. Astellas Pharma Inc; 18.6.1. Company Overview; 18.6.2. Products And Services; 18.6.3. Business Strategy; 18.6.4. Financial Overview
19. Key Mergers and Acquisitions: 19.1. Century Therapeutics Collaborated With Bristol Myers Squibb; 19.2. CellOrigin Biotech Collaborated With Qilu Pharmaceutical; 19.3. Evotec Acquired Rigenerand; 19.4. Vertex Pharmaceuticals Acquired ViaCyte; 19.5. Medipost Acquired OmniaBio; 19.6. Catalent Acquired RheinCell Therapeutics
20. Opportunities And Strategies: 20.1. Global Induced Pluripotent Stem Cell (iPSC) Market In 2027 – Countries Offering Most New Opportunities; 20.2. Global Induced Pluripotent Stem Cell (iPSC) Market In 2027 – Segments Offering Most New Opportunities; 20.3. Global Induced Pluripotent Stem Cell (iPSC) Market In 2027 – Growth Strategies; 20.3.1. Market Trend Based Strategies; 20.3.2. Competitor Strategies
21. Induced Pluripotent Stem Cell (iPSC) Market, Conclusions And Recommendations: 21.1. Conclusions; 21.2. Recommendations; 21.2.1. Product; 21.2.2. Place; 21.2.3. Price; 21.2.4. Promotion; 21.2.5. People
22. Appendix: 22.1. Market Data Sources; 22.2. Research Methodology; 22.3. Currencies; 22.4. The Business Research Company; 22.5. Copyright and Disclaimer